1月6日消息，脑机接口独角兽强脑科技，完成约20亿元融资，投资者包括IDG、蓝思科技、华住、好未 来等。 （文章来源：21世纪经济报道） ...

"很多人追着我要老股。" 作者/冯雨晨 报道/投资界PEdaily 2 0 2 5 年 冬 ， 京 东 前 副 总 裁 、 渐 冻 症 病 人 蔡 磊 接 受 了 一 次 媒 体 采 访 。 此 时 他 已 入 疾 病 终 末期，不能言语，只能通过眼控仪陈述想法。期间蔡磊表示： "已经准备好尝试脑机接口。" 这 项 技 术 正 迎 来 最 好 时 代 。 2 0 2 6 年 开 年 ， 脑 机 接 口 迅 速 爆 红 ， 我 们 获 悉 了 两 则 重 要 事 件： 中国前首富陈天桥，下场参与设立了一家脑机接口公司；杭州六小龙之一强脑科 技被曝完成约2 0亿元融资， 即将递表上市 。 "非常抢手，很多人追着我要老股。"一位强脑科技的早期投资人如是对投资界聊起：这 是 杭 州 六 小 龙 中 唯 一 一 家 医 疗 健 康 公 司 ， 同 时 切 中 了 人 机 交 互 和 脑 机 接 口 两 条 技 术 赛 道，无论在A股还是港股都极具稀缺性。 开年最火赛道 新年火爆一幕正在上演。 2 0 2 6 年 首 个 交 易 日 （ 1 月 5 日 ） ， 脑 机 接 口 惊 艳 四 座 。 A 股 市 场 上 ， ...

格隆汇1月7日丨电广传媒(000917.SZ)在投资者互动平台表示，公司未参与投资强脑科技。 ...

2026年A股开门红，脑机接口相关概念股均迎来暴涨。 自1月5日开始，三博脑科（301293）、翔宇医疗、美好医疗（301363）、伟思医疗、诚益通（300430） 等股票连续多个交易日出现20%涨停，冠昊生物（300238）、塞力医疗（603716）、创新医疗 （002173）、南京熊猫（600775）、岩山科技（002195）等也都连续10%涨停。截至1月7日记者发稿， 脑机接口板块依然涨停不断。 多重利好消息传来 消息面上，埃隆.马斯克近日表示，旗下脑机接口公司Neuralink将于2026年开始大规模生产脑机接口设 备，并将同步推进流程高度精简、几乎完全自动化的外科手术方案。这一表态更是引发脑机接口相关概 念股热度快速攀升。有消息称，量产后，脑机单台植入手术的成本将从百万美元降至10万美元以内，全 自动化落地后有望进一步下探至5万美元区间，为日后脑机接口设备的大规模商业化埋下伏笔。 国内政策层面，2025年7月，工业和信息化部、国家发展改革委、教育部、国家卫生健康委、国务院国 资委、中国科学院、国家药监局七部门联合印发《关于推动脑机接口产业创新发展的实施意见》（以下 简称《意见》），首次系统性地明确了 ...

Core Insights - Strong Brain Technology, a brain-computer interface "unicorn," recently completed approximately 2 billion yuan in financing, making it the second-largest financing in the global brain-computer interface sector, following Neuralink [1] - The financing round attracted prestigious investors, including IDG Capital, Huaden International founded by Intel CEO Chen Lifeng, and several technology and education companies [1] - The brain-computer interface sector has seen a surge in secondary capital, with the sector's stocks rising over 20% in the last three trading days [1] Company Overview - Founded in 2015, Strong Brain Technology is recognized alongside innovative companies like DeepSeek and Yuzhu Technology as part of the "Hangzhou Six Little Dragons" [1] - Unlike Neuralink, Strong Brain Technology focuses on the development of non-invasive brain-computer interface technology [1] - The company's products span rehabilitation medicine, smart health, and intelligent education, with FDA and CE certifications obtained [1] Product and Market Potential - The core product, "Super Sensor," can detect weak brain electrical signals without invasive procedures, converting them into neural signals to control external devices [1] - The product currently assists individuals with physical disabilities in performing activities like running and complex sports [2] - Strong Brain Technology aims to help 1 million disabled individuals regain mobility and assist 10 million patients with Alzheimer's, autism, and insomnia over the next 5-10 years [2] Financial and Investment Highlights - Strong Brain Technology has attracted significant investment since its inception, completing multiple funding rounds, including a $400 million Series A in 2019 and subsequent rounds totaling $30 million and $20 million [2] - As of 2024, the company's valuation stands at 8.5 billion yuan according to the Hurun Global Unicorn List [2] - The company is reportedly preparing for an IPO, potentially in Hong Kong or mainland China, after completing over $100 million in pre-IPO financing by 2025 [2] Industry Trends - According to research from Open Source Securities, brain-computer interface technology is expected to commercialize by 2026, expanding from medical necessities into AI applications and robotics [2] - The commercialization path for non-invasive products is clear, indicating significant revenue potential in the future [2]

Group 1: Industry Overview - Nvidia's CEO Jensen Huang announced at CES that the revenue from existing and future data center chips is expected to reach approximately $500 billion by the end of 2026, with improved market prospects and partnerships with AI providers like Anthropic likely to raise this forecast [2] - The sodium-ion battery industry is projected to see shipments increase from 3.6 GWh in 2024 to 9 GWh in 2025, representing a year-on-year growth of 150%, with key applications in energy storage and light electric vehicles [6] - The lithium iron phosphate (LFP) sector has confirmed successful price increases of 1,500 to 2,000 CNY per ton for major clients, indicating a shift from tentative price hikes to actual implementations, suggesting a recovery phase for the industry [7] Group 2: Company-Specific Insights - Strong Brain Technology recently completed approximately 2 billion CNY in financing, marking it as the second-largest financing in the brain-computer interface sector after Neuralink, with backing from notable investors [3] - Sanhua Intelligent Controls expects a net profit of 3.874 to 4.649 billion CNY for 2025, reflecting a year-on-year growth of 25% to 50%, driven by its leadership in the refrigeration components industry and strong ties with major automotive clients like Tesla and BYD [9] - New Oriental has integrated the Doubao large model, achieving significant breakthroughs in teaching and operational efficiency, with a 24-fold increase in assignment grading efficiency and an 80% reduction in customer service quality inspection manpower [10]

【导读】上午A股三大指数集体大涨，半导体、稀土板块大涨，光刻机概念股领涨 中国基金报记者 张舟 大家好，今天是周三，基金君和你继续关注市场行情！ 1月7日上午，A股三大股指集体上涨，沪指冲击4100点，再创10年来新高，市场量能强劲， 半日成交额超1.8万亿元。 截至午间收盘，沪指报4095.54点，涨0.29%，深证成指涨0.35%，创业板指涨0.41%。 | 最高： 4098.78 | 今开:4083.84 | 成交量: 4.32亿手 | 换手: 0. | | --- | --- | --- | --- | | 最低： 4075.70 | 昨收：4083.67 | 成交额：7617.22亿 | 量比: 1. | | 52周最高: 4098.78 | 上涨： 762 | 振幅: 0.57% | 平盘:74 | | 52周最低:3040.69 | 下跌:905 | 总市值: 66.86万亿 | | 沪深两市半日成交额达1.84万亿元，较上个交易日放量538亿元。 个股跌多涨少，全市场共 2522只个股上涨，88只个股涨停，2773只个股下跌。 上午，稀土永磁概念股强势拉升。 个股方面，中稀有色录得10cm涨停 ...

Core Insights - Elon Musk has provided a timeline for mass production of brain-computer interface (BCI) devices, igniting interest in global capital markets, with related indices in A-shares rising over 13% on the first trading day of the year [1] - Strong Brain Technology recently completed a significant financing round of approximately 2 billion RMB, marking the second-largest financing in the global BCI sector after Neuralink [1] - The Chinese government has included BCI technology in its "14th Five-Year Plan," indicating a strong push towards commercialization and innovation in the industry [1][3] Company Overview - Strong Brain Technology was founded in February 2015 and has developed non-invasive BCI technologies, including smart bionic limbs and sleep aids, achieving FDA and CE certifications [2] - The company has a history of substantial financing, including a $400 million Series A round in 2019, and plans for an IPO in Hong Kong or mainland China with a valuation exceeding $1.3 billion [2] Market Dynamics - The Chinese BCI market is projected to exceed 3.8 billion RMB by 2025, with medical health applications accounting for 56%, and is expected to surpass 10 billion RMB by 2030 [3] - The government plans to invest over 50 billion RMB in the BCI industry during the "14th Five-Year Plan," aiming to cultivate 2-3 global leading companies by 2030 [3] Future Development - Strong Brain Technology aims to accelerate research and development in rehabilitation and consumer sectors, with a vision to assist 1 million individuals with physical disabilities and 10 million patients suffering from brain-related conditions over the next 5 to 10 years [4] - The company emphasizes the importance of making BCI technology accessible to the general public, aligning with the "technology for good" philosophy [4] Global Industry Landscape - Neuralink remains the highest-valued BCI company globally, with a valuation of $9 billion following its Series E funding round in 2025 [5] - The BCI technology is expected to achieve commercialization by 2026, with applications expanding from medical needs to AI and robotics [5] - The global BCI market is projected to grow to approximately $12.4 billion by 2034, indicating significant investment potential in both medical and technological sectors [5]

| 上证指数 | 深证成指 | 科创综指 | | --- | --- | --- | | 4095.54 | 14071.35 | 1746.07 | | +11.88 +0.29% | +48.79 +0.35% +25.66 +1.49% | | | 万得全A | 创业板指 | 北证50 | | 6674.65 | 3332.74 | 1506.61 | | +32.89 +0.50% | +13.45 +0.41% +13.57 +0.91% | | | 沪深300 | 中证500 | 中证A500 | | 4792.05 | 7902.04 | 5880.24 | | +1.36 +0.03% | +87.91 +1.13% +20.03 +0.34% | | | 中证1000 | 深证100 | 中证红利 | | 7930.24 | 5978.96 | 5591.68 | | +65.33 +0.83% -10.65 -0.18% +0.63 +0.01% | | | | 万得全A涨跌分布 | | | | The a my my a | | SIACAA | 记者丨曾静娇 编辑丨刘雪莹 1月7日，A ...

Core Viewpoint - The article highlights the significant financing of approximately 2 billion RMB by Strong Brain Technology, marking it as the second-largest disclosed financing in the global brain-computer interface (BCI) sector after Neuralink, drawing attention from both capital markets and the industry [2][3]. Financing Overview - Strong Brain Technology completed a financing round of about 2 billion RMB on January 6, 2026, with a diverse investor base including financial investors, industrial capital, and strategic investors such as IDG, Huaden International, and Lens Technology [2][14]. - This financing round reflects a continued interest in Strong Brain Technology's existing technology routes and product advancements, indicating confidence in the company's future [3][15]. - The company has a history of securing substantial capital, having previously completed multiple financing rounds, including a 20 million USD B round in 2025 and a 30 million USD Pre-B round [13][14]. Company and Product Development - Founded in February 2015, Strong Brain Technology has evolved into a key player in the BCI field, focusing on non-invasive BCI technology [7][9]. - The company has developed high-precision EEG signal acquisition and analysis technologies, achieving mass production of solid gel electrode materials in 2017, which improved the stability and accuracy of EEG signal collection [9]. - Strong Brain Technology has launched several BCI-related products, including smart bionic hands and legs, and a brain-machine intelligent sleep aid, with some products receiving FDA and CE certifications for international market entry [11][12]. Clinical and Market Progress - Strong Brain Technology's smart bionic hand is the first BCI product in China to receive FDA approval, allowing it to enter over 30 countries and regions by 2025 [12]. - The company holds over 200 core patents in the BCI field, with approximately 60% being invention patents, positioning it favorably in the domestic patent landscape [12]. Policy and Industry Support - The Chinese government has issued implementation opinions to promote innovation and development in the BCI industry, aiming for breakthroughs in key technologies by 2027 and establishing a robust industrial ecosystem by 2030 [16][17]. - Local governments, including Beijing and Shanghai, have introduced action plans to accelerate the application of BCI technologies across various sectors by 2030 [18][19]. Standardization and Ecosystem Development - The National Medical Products Administration released the first industry standard for BCI medical devices, effective January 1, 2026, to unify terminology and support regulatory and industrial collaboration [22]. - Various regions are also advancing infrastructure development to support BCI product research and application [23].